About U.O. di Oncologia Ospedale Villa Scassi
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Canadian Cancer Trials Group
2
Daiichi Sankyo, Inc.
1
NCIC Clinical Trials Group
1
PharmaMar
1
Clinical Trials at U.O. di Oncologia Ospedale Villa Scassi
During the past decade, U.O. di Oncologia Ospedale Villa Scassi conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer
2009-09-04
2015-11-27
Completed
720
A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)
2014-04-30
2016-06-10
Completed
172
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
2014-10-09
2026-01-31
Active, not recruiting
1,415
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
2016-10-07
2023-06-30
Active, not recruiting
520
A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer
2020-12-14
2027-05-14
Recruiting
540
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
2020-12-21
2024-06-27
Recruiting
590
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
2021-05-10
2027-04-09
Recruiting
800
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
2022-07-22
2025-06-01
Recruiting
705
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "U.O. di Oncologia Ospedale Villa Scassi" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Canadian Cancer Trials Group" with 2 trials
sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "NCIC Clinical Trials Group" with 1 trials sponsored and "PharmaMar"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "U.O. di Oncologia Ospedale Villa Scassi"
#1 collaborator was "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator and "Chinese Thoracic Oncology Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at U.O. di Oncologia Ospedale Villa Scassi
According to Clinical.Site data, the most researched conditions in "U.O. di Oncologia Ospedale Villa Scassi" are
"Non-Small Cell Lung Cancer" (2 trials), "Lung Cancer" (1 trials), "Mesothelioma" (1 trials), "NSCLC" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "U.O. di Oncologia Ospedale Villa Scassi" in a lesser frequency.
Clinical Trials Intervention Types at U.O. di Oncologia Ospedale Villa Scassi
Most popular intervention types in "U.O. di Oncologia Ospedale Villa Scassi" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Cisplatin" (2 trials), "Pembrolizumab" (2 trials), "Pemetrexed" (2 trials), "Placebo" (2 trials) and "Alectinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at U.O. di Oncologia Ospedale Villa Scassi
The vast majority of trials in "U.O. di Oncologia Ospedale Villa Scassi" are
8 trials for "All" genders.
Clinical Trials Status at U.O. di Oncologia Ospedale Villa Scassi
Currently, there are NaN active trials in "U.O. di Oncologia Ospedale Villa Scassi".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in U.O. di Oncologia Ospedale Villa Scassi,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in U.O. di Oncologia Ospedale Villa Scassi, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".